The 12th Biennial Ovarian Cancer Research Symposium organized by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research held on September 13–15, 2018 covered cutting edge and relevant research topics in ovarian cancer biology and therapy. Sessions included detection and prevention, genomics and molecular mechanisms, tumor microenvironment and immunology, novel therapeutics, and an education session. In this article we provide an overview of the key findings presented in the tumor microenvironment and immunology session
Ovarian cancer is a heterogeneous disease and recent advances in improving patient outcome havebeen ...
Abstract Development of ovarian cancer involves the co-evolution of neoplastic cells together with t...
Ovarian cancer is the most lethal of all gynecologic malignancies and has witnessed minimal improvem...
In September 2018, the 12th Biennial Ovarian Cancer Research Symposium was presented by the Rivkin C...
In September 2018, the 12th Biennial Ovarian Cancer Research Symposium was presented by the Rivkin C...
The Special Issue on high grade serous ovarian cancer (HGSOC) and the contribution of the tumor micr...
The Special Issue on high grade serous ovarian cancer (HGSOC) and the contribution of the tumor micr...
Reciprocal signaling between immune cells and ovarian cancer cells in the tumor microenvironment can...
Most ovarian cancer patients present with disseminated disease at the time of their diagnosis, which...
Worldwide, Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic ...
Over the previous two decades, there has been a shift in the ovarian cancer paradigm to consider it ...
Simple Summary The ovarian cancer tumor microenvironment is made up of ovarian cancer cells along w...
The second Annual Meeting of the International Ovarian Cancer Consortium (IOCC) was held in conjunct...
Recently, ovarian cancer research has evolved considerably because of the emerging recognition that ...
PhD Theses.Treatment of advanced clear cell ovarian cancer (CCOC) with immune checkpoint inhibition...
Ovarian cancer is a heterogeneous disease and recent advances in improving patient outcome havebeen ...
Abstract Development of ovarian cancer involves the co-evolution of neoplastic cells together with t...
Ovarian cancer is the most lethal of all gynecologic malignancies and has witnessed minimal improvem...
In September 2018, the 12th Biennial Ovarian Cancer Research Symposium was presented by the Rivkin C...
In September 2018, the 12th Biennial Ovarian Cancer Research Symposium was presented by the Rivkin C...
The Special Issue on high grade serous ovarian cancer (HGSOC) and the contribution of the tumor micr...
The Special Issue on high grade serous ovarian cancer (HGSOC) and the contribution of the tumor micr...
Reciprocal signaling between immune cells and ovarian cancer cells in the tumor microenvironment can...
Most ovarian cancer patients present with disseminated disease at the time of their diagnosis, which...
Worldwide, Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic ...
Over the previous two decades, there has been a shift in the ovarian cancer paradigm to consider it ...
Simple Summary The ovarian cancer tumor microenvironment is made up of ovarian cancer cells along w...
The second Annual Meeting of the International Ovarian Cancer Consortium (IOCC) was held in conjunct...
Recently, ovarian cancer research has evolved considerably because of the emerging recognition that ...
PhD Theses.Treatment of advanced clear cell ovarian cancer (CCOC) with immune checkpoint inhibition...
Ovarian cancer is a heterogeneous disease and recent advances in improving patient outcome havebeen ...
Abstract Development of ovarian cancer involves the co-evolution of neoplastic cells together with t...
Ovarian cancer is the most lethal of all gynecologic malignancies and has witnessed minimal improvem...